Friday, December 22, 2023





Meet BETH HANEY, DNP- one of the recognized industry achievers assembled in this aesthetics collaborative and an honored literary contributor of the recently published IMAGE GUIDED AESTHETICS PROCEDURES textbook by Springer Medical Publishing.  Dr. Haney authored a comprehensive study on (Ch4) "FACIAL REJUVENATION AND NON-SURGICAL PROCEDURES" and also co-wrote a remarkable analysis (Ch6) called "FACIAL DANGER ZONES IN AESETHETICS" with Dr. Michelle Zappas.    Dr. Haney is currently faculty at USC teaching health policy, a former Assistant Clinical Professor at UCI, is a member of the American Association for Nurse Practitioners Health Policy Committee, the Southern California AANP state liaison, and served as Chair of the 2022 and 2023 AANP Health Policy Conference. She founded the Luxe Aesthetic Center in Yorba Linda, CA- a high-profile medspa offering professional aesthetic products and treatments catering to private individuals & celebrity clients. Dr. Haney is currently Mayor Pro-Tem and former Mayor (2020) of Yorba Linda, doctor of nursing practice & a nationally certified family nurse practitioner specializing in cosmetic dermatology treatments, business and leadership, & policy.


10/21/2023 - After two years in the making, we congratulate Dr. Robert Bard and his alliance of clinical experts for the launch of "IMAGE GUIDED AESTHETIC PROCEDURES & TREATMENTS".  Springer Medical Publishing proudly presents the first installment in clinical aesthetic procedures. This detailed and up-to-date overview of image-guided procedures focuses on the many aesthetic and reconstructive strategies delivered by some of today's renowned leaders in the clinical aesthetics community. They share their valuable expertise and field-based findings throughout this feature-rich textbook. The wide list of audiences for this text (ie. dermatologists, plastic surgeons, aestheticians, general surgeons) will enjoy an insider's look at each treatment program while providing remarkable field-based knowledge for the general non-medical audience seeking the latest information in non-invasive and minimally invasive aesthetic procedures. 

Produced and edited by Dr. Robert L. Bard, (NYC based cancer diagnostic imaging specialist) this collective project showcases the most highly sought-after cosmetic treatments in each priceless chapter- through detailed breakdowns, experiential insights and a generous graphic tour of before and after progress visuals.  Thanks to the additional safety benefits of clinical imaging, our treatment professionals express added confidence in the pre-operative and post-op areas. In addition, many aesthetics procedures noted also brings significant advantages (of accuracy and efficiency) to the actual treatment process from real-time image guidance. 

AUTHOR LIST (alphabetical)

• Arun K. Garg, DMD
• Beth Haney, DNP
• Cameron Christiansen, BS
• Cameron Rokhsar, MD
• Cari Green, MD
• Elie M. Ferneini, MD
• Gabriel Borden
• January Howard

• John Catanzaro, MD
• Lennard Gettz, EdD
• Lio Yu, MD
• Lucian Fodor MD
• Mairead Moloney
• Marc J.Saltzman, MD
• Mary Nielsen
• Michelle Zappas, DNP

• Noelle Cutter, PhD
• Paul Dreschnack, MD
• Peter A. Everts PhD
• Randall L. Weisel DDS
• Richard Kushner, DPM
• Robert L. Bard, MD
• Samuila Sergiu, MD
• Stephen Chagares, MD

Excerpt from CHAPTER 1: INDUSTRY REVIEW OF THE AESTHETIC INDUSTRY  By: January Howard & Lennard M. Gettz, Ed.D 

The history of cosmetics is reviewed with technologies unfolding less invasive options and more functional solutions involving nutraceutical supplementation with natural resources. Minimally invasive options are documented as is the adaptation of therapy to the Covid-19 pandemic. This chapter dives into the positive and negative implications of aesthetic procedures and how minimally invasive tactics could help advance all procedures focusing on the sake of performance, safety, and longevity 

Conducting an industry review on the current state of the aesthetic industry would be incomplete without shedding a spotlight on social outlook and how it drives consumer activity trends. All aesthetic procedures are promoted to enhance one's overall look and public appeal and are often theorized to elevate one’s self-appreciation. The public desire to achieve this is what supports this multi-million dollar industry to self-generate constant energy to acquire new market support each year. Fig 1. 

Figure 1: Facial injections may avoid nerve and vascular structures under ultrasound image guidance. 

Historically, the study of human nature has shown consistent evidence of aesthetic personalization throughout every social class as part of natural human desire and need for visually expressing personal pride and individualism. To date, there is an ever-growing list of solutions to enhance and improve a person's image, from PRP injections, microneedling,

chemical peels, Botox, and fillers. These procedures have widely grown in popularity throughout the global community because of their affordable cost to the client/patient, their easy access and their immediate performance and effectiveness. 

The future of minimally invasive modalities has projected a major market growth without any signs of slow-down. Introducing aesthetic procedures to just about ANY practitioner, let it be a dentist, an OB/GYN, a plastic surgeon or a urologist offers a natural add-on, exponentially widening the access of these treatments to the community at large. Where dentists and plastic surgeons clearly have their specialized work intact, aesthetic procedures offer a supplemental income and a lucrative addition to their existing service set. For the practitioner, these procedures are a sensible upgrade by adding fairly recognizable protocols and equipment from prior training. 

Practitioners find the integration and learning curve of adapting aesthetic modalities into their existing practice to be quite comfortable and cost-effective. For example, one can be trained to produce their own dermal filler or bio filler by extracting PRP (which is the client's own biologic) by "cooking" the platelet poor plasma. This is instead of purchasing bio filler from any of the existing manufacturers, offering a savings of anywhere from $300 to $800 per box. 

As the industry concepts of beautification evolved and expanded toward clinical procedures, a sensible upgrade is the implementation of IMAGE GUIDANCE- a valuable tool forged by medical diagnostics. For over 30 years, ultrasound imaging has offered great value in clinical applications and is now adding great directive support to injection situations whereby knowing where the veins and bones truly are could be very helpful as a matter of safety. Whether someone is new to conducting injectable treatments or is a seasoned professional, having the reassurance of visual confirmation lowers the likelihood of hitting a vein or creating an occlusion. Reducing or eliminating risk to the client from pain or the stress of a “land mine” event is a major selling point for imaging devices in pre and post procedures. 

The Modern Age of Clinical Aesthetics
Throughout the 20th century, economic and medical industry reports have traced major activity in cosmetic procedures as part of a global consumer trend of personal enhancement investments. Where elective surgical procedures like breast augmentation, liposuction and rhinoplasty once dominated the aesthetic media, the early 1980's brought forth a new wave of Minimally Invasive procedures which forged an entire industry of cosmetic self-rejuvenation. In 1981, bovine collagen was the first agent approved by the FDA for cosmetic injection. It was developed to induce a youthful appearance (as well as address facial deformities) to target smile lines and improve the presence of facial acne scars. The first regulatory approval gave way for dozens of injectable cosmetic filling agents as well as technologies in pursuit of "anti-aging" or facial enhancement. This minimally invasive treatment trend includes chemical peel, dermal fillers, laser skin resurfacing, hair removal techniques, microdermabrasion and others. [1][2] Fig2.

Figure 2: Optical and thermal energy devices build collagen and firm tissue characteristics 

We can track the history of cosmetic enhancement and aesthetic rejuvenation through the timeline of cosmetic body art as the earliest tribal rituals, to the old testament (840 BC) from the book of Esther to ancient Egypt (1,320 BC)[3]. Since ancient times, the concept of cosmetics, and facial enhancement have been part of personal essence- especially for the elite. Often they were used in religious ceremonies - as seen in ancient Egypt - or as cultural identification. [4] Cosmetic products such as creams, lotions, and talcum powders became more globally accessible to the human zeitgeist, supporting pursuits of cultural acceptance, personal enhancement and beauty. Tracking the aesthetic market in the west, skin care products including skin lotions, powders, creams, bleaches, ointments, and cleansers have historically accounted for a large percentage of the American cosmetics and hygiene industry. The claims and perceived notion of smoother, whiter skin is aligned with better health and beauty has become the impression of beauty since the 1800s. Concealing and removing imperfections like freckles, rashes and pimples are also part of the aesthetic objectives. [5] 


1) Breaking down the most popular noninvasive cosmetic treatments, American Society of Plastic Surgeons , Rod Rohrich, MD, FACS | Dallas, TX Friday, June 16, 2017 - noninvasive-cosmetic-treatments  2) The history of injectable facial fillers, Theda C Kontis 1, Alexander Rivkin. National Library of Medicine.  3) History of cosmetics: 4) Library of Congress, History of the Beauty Business: 5) Cosmetics and Personal Care Products in the Medicine and Science Collections 

ISBN 978-3-031-36264-4 ISBN 978-3-031-36266-8 (eBook)

© Springer Nature Switzerland AG 2023. This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microflms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed.The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifc statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG

The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland

Wednesday, December 20, 2023


The following is an anecdotal performance report from an academic series of case studies of the Aspen Laser Apex Model Exploring the science of photobiomodulation therapy (PBMT).   Reports collected were from May 4-July 7, 2023 under the medical supervision of BARD DIAGNOSTIC IMAGING.  Quantitative imaging reports in this review were conducted strictly with the use of 3D Doppler Ultrasound imaging and Elastographic technology and are submitted by Dr. Robert L. Bard.


5-23-2023   1:53:23pm   

Patient presented evidence of edema on both hands / wrists after impact. PBM light treatment occurred on left hand only and is scanned with Doppler Blood Flow and Elastography to identify edema in median nerve.

PATIENT NARRATIVE: Around 5-9, I fell down a flight of stairs and landed on my hands causing major bruising and significant inflamed swelling on both. I used ice on it frequently + 600mg ibuprofen and counted on nature to make it go away.

On 5/23, I experienced a 15 minute demo treatment of the (Aspen) laser on my left hand only. I would say like right away I noticed a difference. I had more flexibility in my wrist right away. It just continued to get better and better (from the treatment). I was able to sleep through the first night without any pain when I rolled over on my hand. The next day, the purple began to fade and it started to turn yellow- indicating recovery. The other hand (untreated) was still purple. It was interesting to see the comparison and that the hand that was treated was the worst hand. I could see the recovery on the spot! And by the second or third day, it was completely gone- and the other hand was still purple. As an athlete, I'm no stranger to bruises and bumps from things like falling off a bicycle. My one experience with this laser therapy was the fastest recovery...I would say by double, if not triple, because the purple started going away right away.    


INITIAL NOTES from 6/21: Lymphedema in the right arm from breast cancer surgery. The patient expressed that lymph node was not painful, but that the arm felt heavy. A scan from the elbow down to the wrist indicated massive subcutaneous edema. Epidermal thickening from 0.2 millimeters to 0.9 millimeters, epidermal thickening, dermal edema from 1mm to 2mm, and the subcutaneous tissue was bulging and firm and expanded to 12mm when the normal side was three millimeters. Patient expressed improvement upon 1 (20 min) treatment/exposure to PBM light therapy.  The ultrasound imaging shows dark edematous thickening of the epidermis to three millimeters, and the elastography confirms the mean of three kpa demonstrating that this is edematous fluid. Adjacent to the edema is a scar which shows up at 4.6 kpa showing that it's harder tissue than the edema.

PHYSICIAN’S NOTES: The importance of elastography in imaging edematous tissue is to find out where the inflammatory edema or backup edema is causing a permanent fibrotic or scarring process. The last study demonstrates that fibrosis or scar formation is now beginning in the tissues of the leg. So medical attention has to be paid to this to reduce the edema that will result in scarification and fibrosis of a permanent nature.


According to the National Institutes of Health, Laser therapy has widely attracted experts’ attention in medical sciences for its proven benefits in areas including (but not limited to) regenerative medicine, cosmetic, dentistry, neurodegenerative diseases and an ever-growing list of disorders. Basic concepts and various kinds of lasers which are applied in medicine report laser therapy’s response to various fields of medicine such as pain reduction and wound healing in several other body organs at high potential for success. [1]

It is reported that the mitochondrial respiratory chain is a suitable chromophore for red to near-infrared light. It can be concluded that mitochondria are appropriate targets in laser therapy (photobiomodulation therapy). It is a well-known fact that mitochondria are the important organelles of the cells which contain critical biomolecules such as reactive oxygen species (ROS), nitric oxide (NO), adenosine triphosphate (ATP), and cyclic adenosine monophosphate (cAMP). It is proposed that laser therapy affects the production of these biomolecules, which is accompanied by the initiation of cell proliferation. This, in turn, induces the signal cascade effects. Recently, researchers have published findings of the role of LLLT in the prevention of endothelial dysfunction development in COVID-19 patients. Based on these investigations, the clinical experience of the treatment and rehabilitation of COVID-19 patients is affected by LLLT. [1]

APEX NEAR INFRARED THERAPY: Upon review of the company’s information: the Apex Laser series is the world’s first and only laser device of its kind, the Apex Tri-Wave Laser Series is changing the way health care professionals are treating pain and injuries. Uniquely featuring three wavelengths of 810nm, 980nm and 1064nm, the Apex Tri-Wave incorporates 15 watts of high power with each wavelength for a combined total output of 45 watts.  Their TRI-WAVE technology capacitates 810nm, 980nm and 1064nm wavelength. The Aspen Laser can deliver more energy than other therapy lasers. More power equates to deeper penetration, faster treatment times and delivery of the proper therapeutic dosage, an enhanced ability to treat difficult conditions, and ultimately better clinical outcomes.

Since the early 1970s, lasers have been categorized in four classes with two subclasses based on a laser’s wavelength and maximum output of power. The classes group lasers according to their ability to produce damage in exposed people, from class 1 (no hazard during normal use) to class 4 (severe hazard for eyes and skin). [Sourced from] HealthTech Reporter™ offers performance reviews of health technologies that received regulatory approvals.  Our diagnostic test drivers have assessed the Apex laser system’s documentation to meet FDA clearance as a Class II Medical Device and a Class IV Laser (CDRH). 


Since march of 2023, Dr. Robert Bard initiated a multi-pathology study of pulsed bioenergy treatments. This specific study is a clinical evaluation of treatments volunteers @ the Bard Diagnostic facility at 121 E. 60th St. NYC. In pursuit of the many reports of success in inflammation reduction, applying the effects of the cellular regenerative properties of photobiomodulation (near infrared) field directly on various pre-confirmed disorders. Supervised exposure shall be provided by Dr. Bard and his research team through the use of real-time 3D Doppler Ultrasound and other non-invasive imaging devices. The initial (Image Guided) treatment shall be conducted @ the NYC clinic where Dr. Bard established base line studies and immediately after, PBM treatments and ultrasound scans under periodical comparative imaging. Dr. Bard recorded any and all progress within the time allotted- collecting any/all quantifiable data about the state of the volunteer’s pathology. Any progress is identified by quantitative blood flow scans or elasographic (tissue elasticity) scans. This information is often collected by the diagnostic imaging technologies selected for this study at Dr. Bard’s scanning devices. 

From simple case studies to double blind clinical trials, the many benefits of non‐invasive imaging offers visual proof of treatment  efficacy.    Ultrasound  in  particular  is  more  widely  used  to  collect  a  patient's  biometric  data  safely  and efficiently, thanks to its vastly improved quantitative reporting capacity.   Under exploratory device tech reviews, this video shows the effects of electromagnetic pulse wave stimulation and the induction of therapeutic lasers on the body are  just  some  of  the  noninvasive  modalities  that  are  easily  monitored  with  an  ultrasound  scan.  In  the  case  of 
electromagnetic devices, the involuntary muscle contraction is evidence of the electrical changes in the targeted muscle developers of this technology continue to find new evidence, supporting its ability to recover the body's process through cellular regeneration on a preliminary study, quantitative measurement that the regenerative timeline through the use of  a  neurostimulator  through  a  simple  before  and  after  comparison  can  easily  show  the  body's  reaction  to  the 
therapeutic device. 


The Mindray Resona 7 platform begins with proprietary and industry-first virtual beam-formation technology, ZONE Sonography® Technology+. The acquisition of larger and more robust acoustic data sets coupled with proprietary, industry-first virtual beamforming methods and innovative signal processing techniques translates into a number of unique imaging advantages. These include extremely fast image processing and display for noticeably improved temporal resolution; exceptional image uniformity throughout the field of view with improved spatial and contrast resolution. ZST+ also has the ability to generate novel and exclusive advanced diagnostic applications while improving the performance of established imaging technologies. Virtual beam formation will continue to shape the future of ultrasound imaging in impactful ways, allowing for more powerful technology, improved workflow tools, and the inclusion of more AI-based advancements. ZST+ has paved the way for the future of ultrasound.

Mindray’s High Fame Rate Sound Touch Elastography utilizes the advantages of ZST+ with smoother transition times and faster refresh rates for more consistent acquisition and assessment during live 2D shear wave imaging allowing for more rapid, reliable, and reproducible quantitative results.  

Advantages include:
- Patented ultra-wide beam tracking technology improves penetration, especially for stiff tumors, fatty livers, and obese patients
- Rapid acquisition with high reliability for improved efficiency and throughput
- Consistent results with high reproducibility
- Four quality measures for improved inter-operator variability and diagnostic confidence: motion stability, tissue homogeneity, reliability map, and reliability overlay visualization
- Continuous-fire STQ acquisition methods for more results in less time, enhancing the patient experience
- Combination STE and STQ mode for continuous-fire point measurement with the added advantage of quality maps 

For complete information on this technology, visit:


The producers of this exploratory performance test (HealthTech Reporter) wishes to thank Dr. Robert Bard for his innovative vision to convert his clinical diagnostic ultrasound imaging facility into a research validation lab for academic and scientific advancement of non-invasive technologies.  Accordingly, we also express our deepest gratitude to Charles Vorwaller, CEO/Founder of Aspen Laser and Mark Murdoch (demo/training advisor) for their vast insight and technical participation and for the generous loan of the Apex Laser model. Further thanks goes to Michelle and Frank marcantonio of Mindray NA for their unending and gracious support and for the loan of the Mindray Resona 7- without whose help this study would not have been made possible.

Monday, December 18, 2023


On average, the prostate is about the size of a walnut. It grows to roughly the size of a Ping-Pong ball, weighing 30 to 35 grams. Within a major portion of adult males, the prostate continues to grow even further up to the size of a tennis ball or larger. The normal prostate gland has measures 3 × 3 × 5 cm approximately or a volume of 25 ml. [1,2] According to statistical reports by Yale Medicine about 50% of men between the ages of 51 and 60 have Benign Prostatic Hyperplasia (BPH) or enlarged prostate, and that number jumps to 70% among men aged 60 to 69 and around 80% of men over 70 years of age [3].  

Complications of BPH includes acute urinary retention, chronic, or long lasting urinary retention, blood in the urine, urinary tract infections (UTIs), bladder & kidney damage or bladder stones.[4]  The most common solution (thus far) to address this condition is medicinally with Alpha blockers.  This is recognized as the recommended first-line treatment for men with mild to moderate symptoms. It is noted that alpha blockers carry a variety of side effects including dizziness and low blood pressure.[5] There are also invasive solutions to enlarged prostate including laser therapy, microwave heat, or prostate tissue compression. Partial prostate removal and full removal are more invasive but may be necessary for extremely large prostate glands.  

As the medical community is (now) pursuing non-invasive alternatives for the many health conditions, addressing hyperplasia continues to be a significant interest in the medical community.  Bard Diagnostics and Wellness Now, under a joint study under the AngioFoundation(501c3) is conducting a preflight study of the effects of Pulsed Bioenergy Therapeutic innovations.  This Image-Guided program employs the use of PEMF (Pulsed Electromagnetic Frequency) technology, or neuromagnetic stimulation to address symptoms of enlarged prostate.

Since March of 2022, Dr. Robert Bard initiated a multi-pathology study of PEMF treatments.  This specific study is a clinical evaluation of the PEMF treatments of four (4) volunteers @ the Bard Diagnostic facility at 121 E. 60th St. NYC. In pursuit of the many reports of Electromagnetic Stimulation providing significant success in inflammation reduction, applying the effects of the cellular regenerative properties of neuromagnetic field directly on a pre-confirmed enlarged prostate gland dictates the same logical path of size reduction in an enlarged prostate.

Supervised exposure was provided by Dr. Bard and his research team through the use of real-time 3D Doppler Ultrasound and other non-invasive imaging devices.  The initial (Image Guided) treatment was conducted @ the NYC clinic where Dr. Bard established base line studies and regular (bi-weekly) PEMF treatments and ultrasound scans under periodical comparative imaging.  In addition, each volunteer took home a personal PEMF device for use twice a day at a given power setting and dosage duration. This preflight study was a one month (30 days) micro-review of the PEMF’s function and a logging of the volunteer’s exposure response via imaging.  Dr. Bard recorded progress within the time allotted- collected quantifiable data about the state of the volunteer’s prostate size and health. Progress verified by a reduction in size, blood velocity (flow) within the immediate prostate area as well as the elasticity or firmness of the prostate tissue.  This information was collected by the diagnostic imaging technologies selected for this study at Dr. Bard’s scanning devices. 


(1) verage size prostate:,weighing%2030%20to%2035%20grams.&text=In%20many%20men%2C%20it%20continues,a%20tennis%20ball%20or%20larger. (2) Ultrasound of the prostate – PMC : (3) Enlarged Prostate (Benign Prostatic Hyperplasia) (4) Prostate Enlargement (Benign Prostatic Hyperplasia): (5) Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia - (6) Prostate resection - minimally invasive - (7) "Enlarged Prostate" - (8) "Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in the Treatment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Model" | National Institutes of Health.- PMID: 24913937- Raffaella Leoci,* Giulio Aiudi, Fabio Silvestre, et al. (9) "Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia"- PMID: 32090492 |  Marta Tenuta, Maria G Tarsitano, Paola Mazzotta et al. (10) "Ultrasound & The Prostate": | prostate#:~:text=Ultrasound%20of%20the%20prostate%20uses,whether%20the%20gland%20is%20enlarged. (11) "Prostate cancer ultrasound treatment as effective as surgery or radiotherapy", by Kate Wighton (04 July 2018). Imperial College London. (12) "Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology"- 2016 Nov 5, | PMID: 27748048 | Maria VadalĂ , Julio Cesar Morales‐Medina, Et. Al. -


INTRODUCTION: By "Cousin" Sal Banchitta
I've had an incredible 30+ year career in the NY Fire Department, what so many of considered to be the best job in the world. There is no other profession that even comes close to the rewards of being a city firefighter. We were the first and last line of defense to protect this great city from any catastrophe and aligned with a special family of the most unique and remarkable men and women is truly the ultimate blessing.

Many of us will back me on this; there is no such thing as a RETIRED FIREFIGHTER. The very spirit to make a difference as a first responder is a calling that stays with all of us until our last day. We are 'built' to stand watch for any threats to our community and be at the ready to do what needs to be done to restore safety and normalcy to the lives of our neighbors. One of many such examples is 9/11- where so many old-timers and active responders from all over the country raced to New York City at a moment's notice to unite with our fellow rescuers. Seeing our city in peril was an instant call to run to the scene without any hesitation and stand next to our fellow rescuers to work and sacrifice everything all over again.

So when it comes to OCCUPATIONAL INJURIES, EXPOSURES AND CANCERS, I co-captained the 'GET CHECKED NOW!" Project with NYCRA because staying proactive is a must-do! This includes staying on top of some of the major concerns in retirement like PROSTATE HEALTH.  When I heard about this PEMF study, I was the first to join as a test case. I proudly announce this (instead of conceal my identity as with most research projects). I wanted the world to know that exploring alternative therapies greatly shaped the world of health and longevity and that non-invasive monitoring is a big part of what Dr. Bard calls "IMAGE GUIDED TREATMENTS". Whomever sees my articles about this tech review and all others that I am involved in, I hope to project the message of maintaining current awareness about what's available out there- as part of staying on top of your health!


NYCRA's own "COUSIN SAL" BANCHITTA, Retired FDNY FF and Cancer Prevention Advocate for the F.A.C.E.S. (Firefighters Against Cancers and Exposures) "Get Checked NOW!" program often partners with Dr. Robert Bard's clinical research team to explore the latest in diagnostic and therapeutic health innovations.

In August of 2023, Sal joined a group of four men over 50 on an exploratory and clinically monitored study applying PEMF (Pulsed Electromagnetic Frequency) to address BPH (Benign prostatic hyperplasia) or enlarged prostate gland. According to Yale Medicine, "about 50% of men between the ages of 51 and 60 have BPH, and that number jumps to 70% among men aged 60 to 69 and around 80% of men over 70 years of age".[1]

This exploratory concept was under a collaboration between Dr. Robert Bard (seasoned diagnostic imaging specialist) and a team of research coordinators from ICRS (Integrative Cancer Resource Society). In expanded technical collaboration with Mr. Patrick Ziemer (AuraWell ness PEMF), this panel launched an exploratory Pilot concept of employing a non-invasive alternative solution to reduce prostate size as part of improving men's overall health. "Historically, we have observed the growing success of pulsed bioenergy frequency on a wide variety of physiological disorders... joining the strength of Dr. Bard's imaging capacity to monitor and validate real-time treatment progress, we have united to launch this micro study... that may someday change the face of how prostate disorders may be managed", states Dr. Noelle Cutter, ICRS Senior Medical Editor & clinical research specialist.

Use of ultrasound imaging has been Dr. Bard's "scanner of choice" when it comes to analyzing and diagnosing a wide array of complex health disorders, from cancer tumors to inflammatory disorders. As a beta tester for developers of ultrasound feature upgrades, Dr. Bard has published an expanded set of findings in support of PEMF regenerative benefits.  His latest pilot study provided quantitative evidence about PEMF-induced micro-tissue and vascular reactions, thanks to his creative use of echocardiography. "Over the years, I have gained significant confidence in Pulsed Bioenergy therapeutic innovations", states Dr. Bard. "...through strategic imaging, we can visibly and quantifiably identify the smallest veins dilating and the contractility of the tissue being energized- appearing as pulse vibrations in the form of the undulating surface line of the muscle. This is how we can illustrate the path of ENERGY MEDICINE in real-time action".

Sal Banchitta, one of four volunteers took home the Nova-HD (by AuraWell PEMF) from the Bard Diagnostic Imaging center in NYC. All case studies are instructed to use the PEMF device as directed- applying electromagnetic exposure via the provided PEMF coil for an est. 20 minutes 2x a day. "Aside from the clicking sound of the power source device, what I learned about PEMF is that it's widely known to be painless and has no known side effects", says Mr. Banchitta. "I also learned this technology to offer so much by ways of pain relief and cell regenerative therapy".

Unlike the other participants of the study, Sal was scheduled to go on a coastal road trip for business immediately after his PEMF consult. The clinical panel found this to be an ideal situation to conduct the test from the drivers seat.  "Adult Americans spend a major portion of their lives behind the wheel... proving how to integrate PEMF treatments while driving could be a great way to optimize use of one's travel time", stated Patrick Ziemer.

"Because I had a limited amount of time and a tight travel schedule, I chose to take advantage of the situation by bringing the PEMF into my truck- and it was easy! I installed an a 110 AC outlet to plug in the device. Sitting on the PEMF coil is the same here as it is in my recliner chair at home. The coil was soft and absolutely comfortable and it wasn't an impediment to my driving at all. I used it for about an hour each day and I had a lot of hours to kill." 

"I have always been a proponent of early detection- especially when it comes to prostate cancer. Four years ago, my annual retirement exam started with a blood test. My primary found my PSA was slightly elevated, so I was then sent to the urologist as standard operating procedure.  Before you know it, I received a report of a "slightly" enlarged prostate which put me into what felt like an automated track to getting a biopsy.  Getting a biopsy without an MRI or any type of imaging made the needle work a complete and painful shot in the dark. Getting poked 12+ times in what felt like complete guesswork was terrible experience. In the end, we found that the biopsy could have been avoided if the PSA reading gave more information, and a more accurate assessment. As a member of a family predisposed to cancer, the stress of waiting for the biopsy, then actually undergoing the procedure thinking I MAY have have cancer or not was completely an unfair ordeal to put anyone through. Meanwhile, this is what launched my journey to support prostate health- including why I am now driving with a PEMF coil on my drivers seat!"


The news feature proudly gives thanks to the AOPP (Association of PEMF Professionals) and Patrick Ziemer of Magnawave Inc. and Aura Wellness PEMF for the technical information provided for interviews and unending support to support our clinical study and educational programs about PEMF technology for chronic disorders and supportive testimonials in alternative therapeutics.   


Procedurally, the best way to study an enlarged hyperplastic prostate gland is as a low grade inflammatory process, similar to women with fibrocystic breasts considered to be breast inflammation. This does not need to be treated with antibiotics since this inflammation is often aligned with a chronic disease and requires a long-term treatment protocol. One example of this therapy is using a pulse electromagnetic applicator (PEMF) which can be applied over the groin area or under the pelvis (even in the car seat). For treatment applications, this protocol is recognized to be safe, painless, comfortable, and user-friendly on a long-term basis.  Reducing low grade inflammation can be managed with relatively low energy treatment over an extended yet controlled period of time.  Daily application of energy therapy inducers to the prostate and bladder area has been proven to reduce bladder urge, the need to urinate and improve the urine flow out of the enlarged prostate. It also decreases the chance of incontinence because the bladder that is more easily emptied is less likely to overflow in an uncontrolled manner.  (CLICK to see complete article)

8/8/2023- Ret. FDNY Sal Banchitta signs in to experience his Whole Body MRI from Prenuvo, NYC- a state of the art imaging company founded out of Vancouver, Canada. As one of the founding cancer awareness producers of NYCRA (NY Cancer Resource Alliance0 and F.A.C.E.S. (Firefighters Against Cancers & Exposures), Mr. Banchitta gladly accepted the invitation to receive this complete body scan as part of his pursuits of a base line for future scans and a preventative measure against cancer. "My mission alongside my fellow advocates is to learn about the latest modalities in diagnostics and treatment to bring awareness about cancer resources to the rescue community", says Sal. Prenuvo’s cutting-edge whole-body scans are based on 10+ years of clinical work while curating the biggest data set of whole-body MRI scans in the world. Unlike conventional MRIs, which take hours and often involve contrast injections, Prenuvo scans for 500+ conditions, including most solid tumors which can be detected as early as stage 1, in addition to aneurysms, cysts, and more – all without radiation, in under an hour. (See full article)

Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

Disclaimer: The information (including, but not limited to text, graphics, images and other material) contained in this article is for informational purposes only. No material on this site is intended to be a substitute for professional medical advice or scientific claims. Furthermore, any/all contributors (both medical and non-medical) featured in this article are presenting only ANECDOTAL findings pertaining to the effects and performance of the products/technologies being reviewed - and are not offering clinical data or medical recommendations in any way. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, never disregard professional medical advice or delay in seeking it because of something you read on this  article or blogsite.


I am a hepatologist working at The University of Padua, in Northern Italy (near Milan). I'm conducting the research on liver elastograph...